A Republican bill with 1 Republican cosponsor · See the cosponsor
Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill is known as the Right to Try for Individualized Treatments Act. It amends the Federal Food, Drug, and Cosmetic Act. The legislation allows patients diagnosed with a life-threatening disease, condition, or severely debilitating illness to use investigational individualized medical treatments. It outlines specific definitions for eligible patients, eligible health care facilities, and investigational individualized medical treatments. The bill also establishes requirements for additional informed consent and details the eligibility of manufacturers to provide these treatments. Finally, it provides exemptions and conforming amendments related to these medical treatments.
Yes
- Scored +6
Does this make health care easier to get in general?
The bill expands patient access to investigational individualized medical treatments for life-threatening or severely debilitating illnesses.
- Scored +5
Would people with disabilities be better off under this?
Provides individuals diagnosed with severe illnesses or life-threatening conditions a legal pathway to try customized medical treatments.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Under Section 2(a), patients diagnosed with a life-threatening disease or condition or a severely debilitating illness are allowed to request access to investigational individualized medical treatments. This is positive because it gives patients with serious health issues a chance to try unique treatments based on their specific genomic profile when other options may not be available.
-
Under Section 2(a), the definition of an eligible patient requires certification from a physician who is in good standing and will not be directly compensated by the manufacturer for that certification. This provides a positive safeguard for patients by helping ensure their doctor's medical assessment is unbiased and focused strictly on the patient's health needs rather than financial incentives from drug makers.
-
Under Section 2(b), manufacturers that comply with applicable federal assurance laws and operate within an eligible health care facility may make investigational individualized medical treatments available to eligible patients. This provision creates a legal pathway for individuals to obtain specialized, patient-specific therapies that target their unique genetic makeup and medical history.
Potential Negative Impacts for People
-
Under Section 2(b), a manufacturer of an investigational individualized medical treatment is explicitly not required to make their treatment available to any patient. This could create a negative outcome or burden for individuals, as desperate patients and their families may be denied access to a potentially life-saving treatment even if they meet all the eligibility criteria.
-
Under Section 2(a), patients requesting these treatments must navigate complex requirements, including providing written informed consent and additional informed consent that includes detailed explanations of approved treatments, physician assessments, and potential outcomes. This could place a heavy administrative and emotional burden on patients and their families who are already dealing with a life-threatening disease or severely debilitating illness.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make health care easier to get in general? — The bill expands patient access to investigational individualized medical treatments for life-threatening or severely debilitating illnesses.
- Demographic And Interest Groups
- Would people with disabilities be better off under this? — Provides individuals diagnosed with severe illnesses or life-threatening conditions a legal pathway to try customized medical treatments.
- 6/8/2026
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Tommy TubervilleRepublican · Alabama